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Abstract
Ca2+ signaling plays an important role in the function of dendritic cells (DC), the professional antigen presenting cells. Here,
we described the role of Calcium released activated (CRAC) channels in the maturation and cytokine secretion of human DC.
Recent works identified STIM1 and Orai1 in human T lymphocytes as essential for CRAC channel activation. We investigated
Ca2+ signaling in human DC maturation by imaging intracellular calcium signaling and pharmalogical inhibitors. The DC
response to inflammatory mediators or PAMPs (Pathogen-associated molecular patterns) is due to a depletion of
intracellular Ca2+ stores that results in a store-operated Ca2+ entry (SOCE). This Ca2+ influx was inhibited by 2-APB and
exhibited a Ca2+permeability similar to the CRAC (Calcium-Released Activated Calcium), found in T lymphocytes. Depending
on the PAMPs used, SOCE profiles and amplitudes appeared different, suggesting the involvement of different CRAC
channels. Using siRNAi, we identified the STIM1 and Orai1 protein complex as one of the main pathways for Ca2+ entry for
LPS- and TNF-a-induced maturation in DC. Cytokine secretions also seemed to be SOCE-dependent with profile differences
depending on the maturating agents since IL-12 and IL10 secretions appeared highly sensitive to 2-APB whereas IFN-c was
less affected. Altogether, these results clearly demonstrate that human DC maturation and cytokine secretions depend on
SOCE signaling involving STIM1 and Orai1 proteins.
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Introduction
Dendritic cells are highly specialized antigen presenting cells
(APC) able to induce both specific immunity and immune
tolerance. Because of these properties, they represent the most
important regulating cells of the immune system [1,2]. On the
basis of information gathered from the tissue where they reside,
DC adjust their functional activity to ensure that protective
immunity is favored while unwanted or exaggerated immune
responses are prevented. Immature DC become mature DC with
functional competences in response to a number of stimuli through
numerous cell surface receptors such as cytokine receptors, TLR
(Toll-like Receptors) or type C lectins [3,4]. It results in a sustained
increase of intracellular Ca2+ acting as a second mediator for T
and B cell receptor signaling leading to gene activation, cellular
proliferation and cytokine secretion [5,6]. The process of DC
maturation induced by extracellular ligands plays a key role in the
immune responses but the calcium signaling mechanisms involved
in this phenomenon are not well understood. A previous study
suggested that a Ca2+ influx (also named CCE, SOCE or CRAC)
might be involved in murine DC maturation [7]. Among different
modalities of Ca2+ entry, the implication of an ion channel
(selective to Ca2+) sensitive to endoplasmic reticulum (ER) Ca2+
stocks, named SOC was shown to control this influx. SOCs can be
activated by ER Ca2+ depletion leading to a Ca2+ influx response
named SOCE (Store-Operated Calcium Entry). This SOCE
allows reloading of ER Ca2+ stocks and is involved in the
regulation of several physiological functions [8].
Although their presence and their functionality were investigat-
ed in murine DC, there are very few data regarding the role of
Ca2+ homeostasis and the role of ion channels in human DC. The
use of a calcium ionophore induced a mature phenotype in human
DC [9], as well as an inhibition of IL-12 secretion [10]. Bagley
et al. showed the involvement of PLC (Phospholipase C) in the
maturation process of DC induced by LPS [11]. Indeed, PLC
activation induced Inositol Triphosphate (IP3) synthesis, which in
turn induced ER Ca2+ stocks release through activation of IP3
Receptor (IP3R).
Store-operated Ca2+ entry (SOCE) appears to be the main
mechanism used by many cell types to initiate signal transduction
[12]. We choose to focus on two recently discovered molecules:
Orai1 and STIM-1 [13]. These two proteins, as they move close to
MHC complex in the immunological synapse, are up-regulated
during T cell activation and provoke cell polarization [14,15]. One
of the implications of Orai1’s and STIM-1’s up-regulation in the
early stages of the immune response is to amplify and ensure
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CRAC channel-mediated Ca2+ signaling for clonal expansion,
differentiation and calcium-dependent regulation of gene expres-
sion in T cells. Severe combined immunodeficiency (SCID)
patients have been associated with lack of both functional ORAI
and STIM-1 [16,17]. Although their presence and their function-
ality were investigated in mouse DC, there are very few data
regarding the role of these proteins in Ca2+ homeostasis and the
role of ion channels in human DC.
These data clearly indicate that Ca2+ signaling via the Orai1/
STIM1 complex is likely to be of importance in immunological
regulation. We aim to investigate the mechanisms by which Ca2+
participates in DCmaturation. To do so we analyzed early events of
DC maturation process and functional consequences of its
inhibition.
Figure 1. Expression of maturation markers in human dendritic cells according to extracellular Ca2+ concentration. DC were cultured
with increasing concentrations of Ca2+(in mM). Cells were harvested and double or quadruple staining was assessed by FACS analysis for the 4
conditions. A – CD83 expression is increased by extracellular Ca2+ concentration. The population showed on this panel is gated on DC-Sign labeling.
The percentage of double (CD86 and CD83) positive cells is shown in panel A. Results are representative of 7 independent experiments. B –
Expression of maturation markers in relation to extracellular Ca2+ concentrations. The same population expressed CD80, CD86, HLA-DR and CD83 in
increasing proportions in increasing extracellular Ca2+ concentration. The percentage of quadruple positive cells is shown in panel B. Graph bars
represent the mean of 6 independent experiments (mean 6 SD, *p,0,05). C – CD25 expression in relation to extracellular Ca2+. Grey histograms
represent the expression of the cell-surface marker CD25. Results represent one out of 7 independent experiments.
doi:10.1371/journal.pone.0061595.g001
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Materials and Methods
1. Generation of Dendritic Cells from Peripheral Blood
Mononuclear Cells (PBMC)
Healthy volunteer’s blood was obtained by cytapheresis after
signed informed consent managed by the French Blood Depart-
ment. PBMCs were isolated by Ficoll Hypaque density gradient
centrifugation (density 1.077, Lymphoprep; Abcys SA, France)
and resuspended in culture medium (RPMI, 10% SVF, 1%
Penycillin-Streptomycin, 1% L-Glutamine) after 2 washings.
Monocyte-derived dendritic cells were prepared after selective
adhesion of monocytes to plastic as previously described [18].
Briefly, PBMC were incubated for 45 min at 37uC in 5% CO2 in
culture flasks (100 million in a 75 cm2-Falcon flask, Becton
Dickinson, Mountain View, CA, USA), non-adherent cells were
discarded and medium containing rhGM-CSF (1000 U/ml) and
rhIL-4 (25 ng/ml) was added. Cells were suspended in culture
medium (containing 1000 U/ml rhGM-CSF and 25 ng/ml rhIL-
4). On day 5, immature DC were harvested (DC-SIGN+/HLA-
DR+ .95%), washed and suspended in culture medium with IL-4
and GM-CSF.
2. Cell treatment
DC were cultured during 18 hours in the presence of several
concentrations of Ca2+ as following; RPMI at 0.4 mM, RPMI
with BAPTA 10 mM to obtain Ca2+ free solution, RPMI with
CaCl2 2 mM and RPMI with CaCl2 4 mM. TLR agonists (LPS
(50 ng/ml), zymosan (25 mg/ml) and TNF-a (20 ng/ml)) as well as
Ca2+ inhibitors such as Thapsigargin (750 nM), D609 (100 mM)
and 2-APB (100 mM) were added directly to immature DC for
18 hours in individual wells. All drugs and chemicals were
purchased from Sigma-Aldrich (St Quentin Fallavier, France).
Cells were harvested, washed and used for analyses in flow
cytometry, mixed culture reaction or spectrofluorometric analysis.
For reagents suspended in dimethyl sulfoxide (DMSO), an equal
volume of DMSO was added to control cultures. At the
concentrations used, DMSO has no inhibitory or stimulatory
effects on DC (data not shown).
3. Solutions
The physiological saline solution (PSS) had the following
composition (in mM): NaCl 140, KCL 5.4, MgCl2 1, NaH2PO4
0.33, CaCl2 1.8, D-Glucose 11.1 and HEPES 10; adjusted to 7.4
with 1 M NaOH. The Ca-free solution had the following
composition (in mM): NaCl 140, KCL 5.4, MgCl2 1, NaH2PO4
0.33, EGTA 1, D-Glucose 11.1 and HEPES 10; adjusted to 7.4
with 1 M NaOH. Thapsigargin (TG), 2-ABP (2-AminoPhenyl
Borate), LPS (Lipopolysaccharide), zymosan and TNF-a were
added to the PSS at concentrations indicated in the figure legends.
4. Fluorescence measurements
Intracellular Ca2+ concentrations were estimated using the
ratiometric fluorescent dye Fura-2. Immature DC were plated on
cover slips (Fluorodish FD35-100, WPI, UK) coated with poly-L-
Lysin (Sigma-Aldrich, St Quentin Fallavier, France) in PSS. Cells
were incubated in PSS containing Fura-2 AM (5 mM) (Sigma-
Aldrich, St Quentin Fallavier, France), the membrane-permeant
acetoxymethyl ester form of Fura-2, diluted in pluronic acid-F127
(Sigma-Aldrich, St Quentin Fallavier, France), during 60–75 min
at 37uC. Cells were then washed with PSS and left for 2 additional
minutes before recording.
Figure 2. Identification of SOCE during the earlier events of DC maturation. DC were treated with thapsigargin (TG) in calcium free PSS,
then PSS supplemented with 2 mM Ca2+ was added (A). 100 mM 2-APB PSS solution induced a rapid and reversible decrease of [Ca2+]i (Grey trace).
According to different maturation signals (LPS, B; TNF-a, C or zymosan, D), the variations of [Ca2+]i in the presence of SOCE inhibitor (Grey trace, at
100 mM 2-APB) or its absence (Black trace) were observed by microspectrofluorimetry on left panels. Results are representative of 7 independent
experiments. Central panels represent the maximal amplitude mean of CCE according to the treatment. Right panels represent the CCE amplitude
mean at 7.5 and 15 min. Means were obtained from 7 independent experiments.
doi:10.1371/journal.pone.0061595.g002
Figure 3. 2-APB decreased the expression of maturation markers in human DC. In panel A, DC were cultured in medium with maturating
agents (TG (750 nM), LPS (50 ng/ml), Zymosan (25 mg/ml) or TNF-a (20 ng/ml)) in the absence or presence of 2-APB (mean of percentage 6 SD,
*p,0,05, n = 7). In panel B, DC were cultured in medium with the maturating agents in the absence or presence of SKF 96365 (100 mM) (n = 7 for DCi,
TG and LPS conditions and n= 4 for Zymosan and TNF-a). The marker expressions were analyzed by FACS as described for figure 1B. In panel C, ORAI-
1 and STIM-1 protein expressions were analyzed by western blotting to control Si-RNA efficacy.
doi:10.1371/journal.pone.0061595.g003
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Samples were analyzed with a Nikon Eclipse TE2000-S
inverted epi-illumination microscope (Nikon, France). The exci-
tation light source was a 75-W Xenon arc lamp. Excitation light at
the two-excitation wavelengths maxima of Fura-2 (340/380 nm)
was chopped by a monochromator (Cairn Optoscan, UK). The
excitation protocol was a 50 ms excitation at each wavelength
every 2 s. Excitation light was directed through a 606 oil
immersion objective with a numerical aperture of 1.4 (Nikon Plan
Apo, France). Fluorescence emissions at 510620 nm were
detected by a photomultiplier tube (PMT) placed on the side of
the microscope. The analogical signals of PMT were digitized by a
Digidata 1322, a converter (Axon Instrument, USA) at a sampling
frequency of 2 kHz. This numeric signal was analyzed using
Clampex 8.2 (Axon Instrument, USA). Background fluorescence
was determined at 340 and 380 nm from an area of the dish free
of cells after experiment and was routinely subtracted.
5. Flow Cytometric Analysis
Dendritic cells were incubated at 4uC with saturating concen-
trations of fluorochrome-conjugated mAbs (CD80, CD86, CD83,
CD25, HLA-DR and DC-SIGN) in the dark for 30 min, washed
twice with PBS, fixed in 0.5% PFA-PBS solution and analyzed
with a FACSCanto (Becton Dickinson, France). Dead cells were
gated out on the basis of their light scatter properties. Data were
analyzed with Diva Software.
For intracellular detection of IFN-c, cells were incubated in
Golgistop solution (Becton-Dickinson) for the last 5 hours of
culture; next the cells were permeabilized with BD cytofix/
cytoperm solution (Becton-Dickinson, France) and finally labeled
with an APC-coupled antibody specific for IFN-c (Becton-
Dickinson, France) according to the manufacturer’s instructions.
6. Enzyme-linked immunosorbent assays (ELISA)
Cell culture supernatants were harvested and stored at 280uC
until assayed for cytokines. Human IL-10, IFN-c and IL-12 p70
concentrations were measured by ELISA using Ready-Set-Go kits
from e-Bioscience (Montrouge, France) according to the manu-
facturer’s instructions. Briefly, microtiter plates were coated
overnight at 4uC with antibodies specific for IL-12p70, IL-10
and IFN-c, from e-Bioscience (Montrouge, France). The plates
were washed and blocked according to the manufacturer’s
instructions. Samples and standards were analyzed in triplicate,
and tested with the avidin-peroxydase system. Optical densities
were measured in an ELISA plate-reader at 450 nm wavelengths.
7. RNA extraction and Real-time PCR
Total RNA was isolated using RNA extraction minikit (Qiagen,
Germany) following the manufacturer’s protocol. RNA yield and
purity were determined by spectrophotometry, and only samples
with an A260/A280 ratio above 1.6 were kept for further
experiments. Prior to reverse transcription, total RNA was treated
with DNAase I for 30 min at room temperature. RNA was then
reverse-transcribed using Superscript II reverse transcriptase and
oligodT (Invitrogen, France). Quantitative (real time) PCR
experiments were performed with a Lightcycler 480 (Roche,
France). The PCR protocol consisted in a denaturizing step at
95uC for 2 min, followed by 35 cycles of amplification at 95uC for
15 s, 60uC for 30 s, and 72uC for 10 s. The experiments were
performed in duplicate, and negative controls containing water
instead of first strand cDNA were done. The results were
calculated with the DCt method, where the parameter Ct
(threshold cycle) is defined as the fractional cycle number at
which the PCR reporter signal passes a fixed threshold. Primers
used for PCR experiments had the following sequences (expected
sizes): STIM-1, forward 59-GCATCTTGCCTGGAGACCGT-39
and reverse 59-CAAGACGGACGCATACATCC-39; ORAI1,
forward 59- GTCACCTACCCGGACTGGAT-39 and reverse
59- TGGAGGCTTTAAGCTTGGCG-39. In order to prevent
amplification of genomic DNA, forward and reverse primers used
spanned neighboring exons.
8. Immunofluorescence and confocal analysis
For immunofluorescence labeling of STIM1 and Orai1, DC
were spun on glass LAB-TEK (Nunc International, USA) coated
with Poly-L Lysine (Sigma-Aldrich, France). Cells were permea-
bilized and fixed by BD Cytofix/Cytoperm TM Plus kit (BD
Biosciences, USA) in labeling medium (PBS with 4% FBS and
0,1% Azide) at room temperature. After fixation, samples were
then incubated with purified antibodies diluted in labeling medium
during 1 hour at room temperature. As primary reagent, we used
as primary antibody a monoclonal mouse anti-human STIM-1
(Santa Cruz USA) and polyclonal rabbit anti-human Orai1 (Santa
Cruz, USA). After washing cells twice with labeling medium,
specific staining was detected by Alexa Fluor 488 conjugated goat
anti-mouse IgG and Alexa Fluor 564 conjugated goat anti-rabbit
IgG (Invitrogen, France), for STIM-1 and Orai1 respectively.
Cover slips were placed in mounting medium (Invitrogen, France)
and visualized with a LMS510 meta Zeiss confocal microscope
equipped with a x63 water immersion objective (NA: 1. 2). Images
shown are single optical slides, with the double labeling.
9. RNA interference
Pre-designed si-RNAs (Santa Cruz Biotech, USA) specific for
STIM1 or Orai1 were used to inhibit STIM1 and Orai1
expression. In each experiment, 4.105 immature DC were plated
in 24-well plates in 400 ml growth medium (Opti-MEM containing
10% FBS without antibiotic). Lipofectamine RNAi-Max (1 ml/
well; Invitrogen, France) was first diluted in 50 ml Opti-MEM
(Invitrogen, France) for 5 minutes before being mixed with an
equal volume of Opti-MEM containing 20pmol of siRNA. After
20 minutes, 100 ml of the Lipofectamine/siRNA mixture were
added to the cells to perform siRNA transfection. Fresh growth
medium (500 ml) was added 4 hours after transfection. Cells were
cultured for 36 hours at 37uC to obtain optimal silencing of
targeted genes. The efficiency of gene silencing was evaluated by
western blot and flow cytometry. A siRNA Control (Santa Cruz
Biotech, USA) was tested as negative control. The sequence of this
siRNA Control is not specific to any genes. Interference
efficiencies were evaluated by western blotting using a monoclonal
antibody anti-STIM-1 (clone H180) and polyclonal anti-Orai-1
(clone H46) from Santa Cruz Biotechnology.
10. Statistical analysis
Statistical analyses were performed using a nonparametric
Mann – Whitney test with XLSTAT 2007 software. For all tests, a
p-value of ,0.05 was considered statistically significant.
Figure 4. 2-APB decreased the cytokine secretions in human DC. IL-12 (panel A), IL-10 (panel B) and IFN-c (panel C) were measured in
supernatants of DC treated by maturating agents (TG (750 nM), LPS (50 ng/ml), zymosan (25 mg/ml) or TNF-a (20 ng/ml)) for 18 h in the presence of
100 mM 2-APB. In each graph, the black line represents the mean of 7 experiments, (*p,0,05).
doi:10.1371/journal.pone.0061595.g004
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Results
1. Extracellular calcium induces mature DC phenotype
We evaluated the expression of DC cell surface markers of
maturation in presence of different calcium concentrations by flow
cytometry. An increased extracellular Ca2+ concentration resulted
in an increase of expression of CD83 and CD86 (Fig. 1A). We
analyzed the percentage of DC quadruple positive cells (CD86/
HLA-DR, CD80, CD83) in Fig. 1B. This percentage increased in
parallel with the extracellular Ca2+ concentration (from 2 to
4 mM). The surface expression of CD25 increased from 24.6% to
43.3% when the extracellular Ca2+ concentration increased from
0.4 to 4 mM (Fig. 1C). In comparison, only 2.7% of DC expressed
CD25 at their surface in the absence of Ca2+.
2. CRAC channel-mediated Ca2+ influx promotes DC
maturation
Since we demonstrated that extracellular calcium was able to
modify the expression of phenotype markers in DC, we
hypothesized that a calcium entry occurs during the earlier events
of DC maturation. In Ca2+ free solution, TG induces store
depletion. Calcium reintroduction induces a CCE sensitive to 2-
APB. So, a SOCE following calcium store depletion (from ER
stocks) was observed in human DC after application of TG, and it
was sensitive to 2-APB (Fig. 2A). In addition, DC stimulation with
TLR agonists resulted in a rapid and sustained increase in [Ca2+]i
suggesting that maturation was accompanied by CRAC channels
activation (Fig. 2B, 2C and 2D). PSS solution perfusion with
100 mM 2-ABP significantly reduced but did not fully eliminate
[Ca2+]i increase following LPS, zymosan or TNF-a treatments.
Figure 5. Localization of STIM-1 and Orai-1 in DC. The expression of Orai-1 and STIM-1 was analyzed at the transcriptional (A and B) or
translational (C) level. Quantitative RT-PCR analysis of Orai-1 (A) and STIM-1 (B) mRNA showed their expression profile for different maturating stimuli
(mean6 SD). The protein expressions of STIM-1 and Orai-1 were analyzed by confocal microscopy using specific antibodies coupled with a secondary
antibody: Alexa FluorH-488 for STIM-1 (green) and Alexa FluorH-555 for Orai-1 (red). The cells were treated with maturating agents (TG (750 nM), LPS
(50 ng/ml), zymosan (25 mg/ml) or TNF-a (20 ng/ml)) during 18 hours.
doi:10.1371/journal.pone.0061595.g005
Figure 6. Inhibition of SOCE in DC by si-RNA (si-STIM-1 and si-Orai-1). CCE was analyzed on DC treated by specific Orai-1 (grey line) and
STIM-1 (light grey line) si-RNAs for 36 h; DC were exposed to TG (in Ca2+-free solution) next, Ca2+was re-introduced (PSS, Ca2+ at 2 mM), a PSS solution
with 2-APB (100 mM) was perfused on si-Ctl cells (black line) by microspectrofluorimetry (A). In panel B, the mean amplitude of intracellular Ca2+
concentration is represented by bar graphs (5 experiments, mean 6 SD, *p,0,05). The siRNA efficiencies were controlled by protein expression
analysis using western blotting (C).
doi:10.1371/journal.pone.0061595.g006
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For LPS, Ca2+ entry presented higher amplitude compared to
those observed with zymosan and TNF-a (0.061 versus 0.034 and
0.018). Moreover, the continuous component in SOCE was
sensitive to 2-APB after 10 min (Fig. 2B and 2C). In contrast, only
a transient and reversible increase of [Ca2+] was observed in
zymosan condition (Fig. 2D). A decrease of the zymosan-induced
SOCE amplitude was observed in presence of 2-APB with a lesser
effect compared to LPS and TNF-a (0.016 versus 0.008 and 0.009)
(Fig. 2D versus 2B and 2C).
3. Both maturation and cytokine secretions depend on
CRAC channels in DC
In DCi, quadruple positive cells represented 6.3% of the DC
population. During the next 18 hours of culture in presence of
different maturating agents, the expression of these markers
increased up to 31.1% with TG, 57.2% with LPS, 57.3% with
zymosan and 31.4% with TNF-a treatment (Fig. 3) As shown in
figure 3A, the treatment of DC by 2-APB during 18 h decreased
the percentage of quadruple positive cells (p,0.005) to 50% for all
conditions. Treatments with SKF 96365 did not significantly
change the marker expression level on DC whatever the
maturating agents (Fig. 3B).
Cytokine secretion by DC is an essential step leading to T cell
activation and polarization. We therefore evaluated DC cytokine
secretion by ELISA using different inhibitors (TG or 2-APB) and
maturating agents. TG-treated DC were not able to secrete any
cytokine tested (Fig. 4). In our conditions, LPS-treated DC
secreted IL-12, IL-10 and zymosan-treated DC secreted IL-10
(Fig. 4A and 4B). These cytokine secretions were abolished in
presence of 2-APB (Fig. 4) or SKF 96365, another inhibitor of
SOCE (data not shown). Secreted IFN-c was also significantly
reduced for TNF-a and LPS -DC (p,0.05) by 2-APB addition and
not for zymosan-matured DC.
4. Both Orai1 and STIM1 proteins are expressed in DC
In order to show both Orai1 and STIM1 mRNA and proteins
on DC, quantitative RT-PCR (Fig. 5A, and 5B) and confocal
microscopy (Fig. 5C) analyses were conducted using specific
primers and fluorescent-labeled antibodies. The Orai1 transcript
was never regulated whatever the treatment conditions (Fig. 5A).
The Orai1 transcript was over-expressed in all culture conditions
in the presence of 2-APB (Fig. 5A). Comparatively, STIM-1
transcript expressed by DCi and its expression was unmodified by
all maturating agents (Fig. 5B). Treatment with 2-APB did not
affect STIM-1’s expression at the transcriptional level, except in
TG condition in which STIM-1 mRNA seems to be up-expressed
(Fig. 5B). The Orai2 and Orai3 mRNA expressions were not
modified by the different treatments as tested in real-time PCR. By
the same way, STIM2 mRNAs were not observed whatever the
DC maturation condition (data not shown).
We then evaluated the protein expression of Orai1 and STIM-1
in DC, at 18 h of maturation, by confocal microscopy (Fig. 5C).
These two proteins appeared to be co-localized on the same cells
for all conditions except for zymosan. In this condition, puncta of
Orai1 (in red) were observed and STIM-1 (in green) was not
detectable in the structures, as it appeared homogeneously
distributed in DC (Fig. 5C).
5. Inhibition of both Orai1 and STIM-1 affects DC
functionality
2APB is a non-selective blocker of store-operated channels and
even it can block other channels. To determine more accurately
the channels involved in the process of maturation of DCs, we
chose to evaluate the involvement of Orai1 and STIM1 in DC
functionality. To do so, a siRNA strategy was used against these
proteins in presence of maturating agents. As we obtained an
efficient inhibition (Fig. 6C), we first checked whether a SOCE was
Figure 7. Orai-1 and STIM-1 inhibition decreased the maturation marker expressions on DC. DC treated by si-Ctl (white), by si-STIM-1
(light grey) or by si-Orai-1 (dark grey) were maturated by following maturating agents (TG at 750 nM, LPS at 50 ng/ml, zymosan at 25 mg/ml or TNF-a
at 20 ng/ml) for 18 h. Then, cells were harvested and quadruple staining (CD80, CD86, CD83, CD25) was assessed by FACS analysis for each condition.
The results represent the mean of percentage of quadruple positive cells from 5 independent experiments (mean 6 SD, *p,0,05).
doi:10.1371/journal.pone.0061595.g007
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observed in the presence of a siRNA control (Black trace in
Fig. 6A). Ca2+ (2 mM) was re-introduced in a perfused solution,
after a treatment by 750 nM TG in Ca2+ free solution. This re-
introduction provoked a sustained increase of intracellular calcium
in DC (F340/F380 around 0.25). The profile of this SOCE is
comparable to that obtained in figure 2A. In Si-STIM1 condition,
the SOCE induced by TG treatment decreased (F340/F380
around 0.09). The SOCE amplitude was equally diminished by a
treatment with Si-Orai1 (F340/F380 around 0.10) (Fig. 6B).
The involvement of Orai1 and STIM1 in DC maturation was
also studied by the analysis of surface markers’ expressions such as
CD83, CD86, CD80, and HLA-DR. The increase of the
expression of these markers observed in figure 3, with TG, LPS,
zymosan and TNF-a was reduced by a treatment with si-STIM1
or si-Orai1 (Fig. 7).
Discussion
The data reported here clearly underline the importance of
Ca2+ in human dendritic cells (DC) maturation, and support an
important role for Orai1 and STIM1 in DC functions. Further-
more, we report for the first time that maturating agents, such as
TLR agonists or cytokines, act through a SOCE in DC. The
stimulation of DC with TLR agonists induces a SOCE (Store
Operated Calcium Entry) which is inhibited by 2-APB (100 mM), a
known inhibitor for this kind of Ca2+ entry. This SOCE is involved
in DC functions as demonstrated by the 2-APB inhibition of the
expression of maturation markers (principally CD25 and CD83)
and of the production of cytokines (IL-12, IL-10 or IFN-c). These
results were confirmed for both properties in DC through si-RNA
experiments. So, we identified the STIM-1 and Orai1 channel
complex as one of the main calcium pathway for DC maturation.
In mouse DC models, different SOCEs have been shown using
TG and nifedipine (a L-type calcium channel inhibitor) [7]. The
evidenced SOCE appears following a total Ca2+ depletion from
the ER. Previous work has shown that CRAC channels are one of
the main calcium pathways in the mouse [19]. The ion channels
responsible for this depletion are IP3R or members of the RyR
family (RyR1, RyR2 or RyR3). In murine DC, the RyR1 protein
was shown to be functional contrary to what has been reported in
human DC [20,21]. In our hands, the SOCE profiles so obtained
distinguished two types of maturating agents, those such as TNF-a
and LPS, able to induce an irreversible SOCE with two
components, and zymosan that induced a reversible SOCE with
a unique component. The SOCE induced by TNF-a and LPS
comprised one component that appeared 2-APB-insensitive and
transient, and another, which was sustained and 2-ABP-sensitive.
As for zymosan, the SOCE was reversible upon washing and less
sensitive to 2-APB. This SOCE reversibility suggested that there
are at least two different Ca2+ pathways used for SOCE in DC.
Moreover, the SOCE amplitude also discriminated two categories
of maturating agents, those inducing a SOCE with high amplitude
such as LPS and those inducing a lower response such as TNF-a
and zymosan. Dantrolene (a RyR1 inhibitor) had no effect on the
SOCE induced in DC by TG, LPS, zymosan and TNF-a (data not
shown). Our characterization of these SOCEs is mainly based on
pharmacological studies using 2-APB, which is known to block
different channels such as TRPC 1, 3, 4, 5 and 6, or SKF 96365, a
potent inhibitor of TRPC 6 and 7 [22]. The SOCE induced by
TG or TLR agonists in DC, was inhibited by SKF 96365 (Fig. 3B),
suggesting the involvement of TRPC 6 and 7 as it has been
observed in cancer cells [23]. The 2-APB specificity did not
allowed the discrimination of the respective role of IP3 receptors
and the membrane channels responsible of the CCE observed.
Our most striking finding was that the principal component of
the SOCE induced by store-depletion appears mainly due to
Orai1 and STIM1, the CRAC channel pore subunit and its
activator, respectively, which are rapidly recruited to induce a
Ca2+ influx after TLR or TNF-R activation. In mast cells, these
two proteins are recruited by the activation of FceR leading to the
Ca2+ increase necessary to degranulation [24]. For mouse DC
maturation, STIM2 seems to be the main component of the
SOCE channel in the early maturation events [25]. In human DC,
STIM -2 expression was not observed. But, we showed that both
STIM-1 and Orai1 mRNA and protein expressions are modulated
in DC treated with different maturating agents. The complex
Orai1 – STIM1 appeared as mainly involved in the maturation by
TNF-a and LPS but to a lower extend by zymosan. A treatment of
DC with specific si-RNA (si-STIM1 or si-Orai1) induced a
dramatic decrease in the SOCE’s amplitude but not its abolition,
indicating that only part of it might be due to the Orai1/STIM1
complex. The fact that we dramatically abolished by si-RNA
STIM-1 definitely demonstrated that DC maturation and
maturation marker expression are under the control a CCE
involving mainly STIM-1 and Orai-1 as no changes were observed
on TRPC expressions [26].
To build a functional channel, tetramers of the Orai1 protein
and STIM1 Ca2+ sensor must interact to allow Ca2+ entry into the
cytosol [27]. Indeed, these two proteins appeared to be co-
localized in DC stimulated by the maturating agents used. When
TNF-a was applied, the maturation markers were lesser expressed
than in the one induced with LPS or TG, indicating that the
coupling between these two proteins has demonstrated lower
intensity. When zymosan is used, these proteins do not seemed not
to be as clearly co-localized. The Orai1 labeling on zymosan-
treated DC only showed structures as puncta. Indeed, zymosan is
taken up in mouse and human DC forming phagocytosis vesicles
following membrane modeling [28,29]. Taken together the results
obtained with SOCE profiles, siRNA assays and confocal
microscopy, the TLR2-agonist zymosan may induce DC matura-
tion using a different molecular calcium pathway than the TLR4-
agonist LPS and TNF-a, which remains to be determined. It is
therefore possible that different ion channels could be involved in
affecting specific SOCE profiles as TRPC, Orai1 and STIM1 that
can form heteromeric complexes [27,30] or other members of the
TRPC or ORAI families such as Orai3 in cancer cells [31].
Signaling through either TLR2 or TLR4 induces the matura-
tion of DCi and modulates the expression of cytokines, i.e., induces
IL-12, IL-10 and IFN-c synthesis. Depending on the maturating
agents used on DC, cytokine secretions appeared differently
sensitive to SOCE inhibitors. Because of the DC purification
method, we cannot completely spread out the possible effect of
contaminating T lymphocytes. Nevertheless, the secretion of IL-12
was totally abolished by 2-APB treatment in LPS-treated DC. We
could hypothesize that IL-12 secretion is related to the Ca2+
amplitude observed in SOCE. The IFN-c secretion was less
inhibited in zymosan-matured DC in comparison to LPS and
TNF-a condition. This secretion might be more related to high
and constant cytosolic Ca2+ level as demonstrated the continuous
part of SOCE profile. We could hypothesize that according to
intracellular Ca2+ concentration and the kinetics, various pathways
might be induced leading to the cytokine secretions. Both TLR
and GPCR receptor signaling have substantive roles in the
regulation of DC function. Indeed, in mouse and human models,
activation of TLR-4, a GPCR, provokes the recruitment of G
proteins and their regulators (RGS: regulator of G protein
signaling) [32]. Moreover, the cytokine production (IL-12,
essentially) is regulated by GPCRs in human monocytic lineage
SOCE Master Human Dendritic Cell Maturation
PLOS ONE | www.plosone.org 10 May 2013 | Volume 8 | Issue 5 | e61595
[33]. The IFN-c secretion is mainly dependent on calcineurin and
NFAT pathways [34]. Another Ca2+-dependent pathway such as
the Calmodulin-kinase pathway could be involved in cytokine
secretion in DC [35,36]. This pathway is involved in zymosan-
activated murine macrophage for IL-10 secretion [37].
Beyond its effect on the early SOCE in DC maturation, the
Orai1/STIM1 complex might have an impact on the whole
immune physiology through ionic homeostasis in DC as well as in
T cells [6]. The clinical phenotype associated with STIM-1
deficiency in patients is very similar to that of Orai1 deficiency,
suggesting that both genes act in the same pathway and are critical
for SOCE in the same tissues [17]. Additionally, deregulated ion
homeostasis has been associated with pathophysiological processes
in inflammation and autoimmune diseases [38,39,40,41]. In fact,
the Orai1/STIM1 complex because of its role in DC physiology
could be a good target candidate for ion channels inhibitors in
immuno-modulatory treatments.
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